Weight Loss Composition with Standardized Natural Extracts
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current obesity management methods, including pharmaceutical drugs and natural extracts, often have limited efficacy and side effects, and there is a need for a safe and effective combination therapy to address obesity and related conditions such as liver dysfunction and kidney damage.
Innovation Solution
A composition comprising standardized extracts of Cyperus rotundus (3-5% total stilbenes), Garcinia sp. (20% garcinol), and Coleus forskohlii (not less than 10% forskolin), which is administered in specific doses to reduce body weight, increase lean body mass, and normalize liver and kidney function markers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If pharmaceutical drugs like orlistat are used for weight loss, then weight reduction is achieved, but side effects occur and risk-benefit ratio is low
Solution Approach 1:
The patent combines multiple natural extracts (Garcinia cambogia containing hydroxycitric acid, Cyperus rotundus containing stilbenes, and Coleus forskohlii containing forskolin) into a single composition. This synergistic combination achieves weight loss through multiple mechanisms (inhibiting fat synthesis, activating fat breakdown, modifying gut microbiome) while maintaining safety by using natural compounds with established safety profiles, thereby resolving the contradiction between effectiveness and side effects
Solution Approach 2:
The invention creates a composite formulation integrating three distinct natural extracts with complementary mechanisms of action. Garcinia provides HCA for inhibiting ATP-citrate lyase, Cyperus contributes stilbenes for adiponectin enhancement and cholesterol reduction, and Coleus adds forskolin for cAMP activation and lipase stimulation. This composite approach achieves superior weight management efficacy while maintaining safety through the use of natural, well-tolerated components
2Object-affected harmful factors
If single natural extracts are used for obesity management, then safety is improved, but efficacy is limited
Solution Approach 1:
The patent merges three natural extracts with different mechanisms of action into a unified composition. Garcinia cambogia inhibits fat synthesis through HCA, Cyperus rotundus promotes fat oxidation and reduces cholesterol via stilbenes, and Coleus forskohlii activates lipolysis through forskolin. This combination achieves synergistic weight loss efficacy while preserving the safety advantages of natural compounds, effectively resolving the contradiction between safety and efficacy
3Productivity
If combination therapies are used, then efficacy is increased through synergy, but treatment complexity increases
Solution Approach 1:
The patent consolidates three active natural extracts into a single integrated composition with standardized concentrations (Garcinia cambogia 50-100mg providing HCA, Cyperus rotundus 100-200mg providing stilbenes, and Coleus forskohlii 25-50mg providing forskolin). This unified formulation delivers synergistic weight loss effects through multiple mechanisms while simplifying administration to a single daily dose, thereby achieving high efficacy without increasing treatment complexity
Solution Approach 2:
The combined composition performs multiple functions simultaneously: HCA from Garcinia inhibits fat synthesis, stilbenes from Cyperus reduce cholesterol and enhance adiponectin, and forskolin from Coleus activates lipolysis and brown adipocyte activity. This multi-functional approach addresses various aspects of obesity metabolism through a single treatment, achieving comprehensive efficacy without requiring multiple separate therapies
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively reduces body weight, improves lipid profiles, and normalizes liver and kidney function markers, providing a synergistic approach to managing obesity and related conditions without significant side effects.
Implementation Method 1
Forskolin the cAMP activator, is known to activate hormone sensitive lipase and induce fat hydrolysis and increase mitochondrial uncoupling protein to tranactivate brown adipocytes
Implementation Method 2
Garcinol is reported to modify the gut microbiome in favor of Akkermansia species apart from activating the genes related to adipocyte browning
Implementation Method 3
3-5% total stilbenes from cyperus prevent adipogenesis, increase adiponectin and reduce cholesterol and leptin leading to an overall loss in weight
Data Source
AI summary
The present invention discloses a composition comprising extracts of Cyperus rotundus, standardized to contain 3-5% w/w total stilbenes, extracts of Garcinia sp., standardized to contain 20% w/w garcinol and extracts of Coleus forskohlii standardized to contain not less than 10% w/w forskolin for the therapeutic management of diet induced obesity and weight gain and related conditions like liver dysfunction, NASH, NAFLD, liver cirrhosis, hypercholesterolemia, hyperlipidemia, kidney dysfunction by bringing about a reduction in body weight, increasing lean body mass and by normalizing the levels of liver enzymes, kidney markers and circulating lipids.